ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1066

Assessing Disparities in Outcomes and Processes of Care for Patients with Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network

Julia Harris1, Catherine Bingham2, Sheetal Vora3, Jon Burnham4, Cagri Yildirim-Toruner5, Tzielan Lee6, Kerry Ferraro7, Erik Friedrichsen8, Katelyn Banschbach9, Michelle Batthish10, Danielle Fair11, Mileka Gilbert12, Beth Gottlieb13, Melissa Mannion14, Edward Oberle15, Nancy Pan16, Natalie Rosenwasser17, Mary Toth18, Jennifer Weiss19 and Esi Morgan17, 1Children's Mercy Kansas City, Overland Park, KS, 2Penn State Children's Hospital, Hershey, PA, 3Atrium Health Levine Children's Hospital, Charlotte, NC, 4Children's Hospital of Philadelphia, Bryn Mawr, PA, 5Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, 6Stanford University School of Medicine, Palo Alto, CA, 7Pediatric Rheumatology Care and Outcomes Improvement Network, Cincinnati, 8Seattle Children's Hospital, Burien, WA, 9cincinnati Children's hospital, Villa Hills, KY, 10McMaster Children's Hospital, Hamilton, ON, Canada, 11Medical College of Wisconsin/Children's Wisconsin, Wauwatosa, WI, 12Medical University of South Carolina, Charleston, SC, 13Cohen Children's Medical Center, Northwell Health, Lake Success, NY, 14University of Alabama at Birmingham, Birmingham, AL, 15Nationwide Children's Hospital, Columbus, OH, 16Hospital for Special Surgery, New York, NY, 17Seattle Children's Hospital, seattle, WA, 18Nemours Foundation, Orlando, FL, 19Joseph M. Sanzari Children's Hospital and Hackensack Meridian School of Medicine, Hackensack, NJ

Meeting: ACR Convergence 2025

Keywords: Disparities, Juvenile idiopathic arthritis, Outcome measures

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: (1055–1087) Healthcare Disparities in Rheumatology Posters

Session Type: Poster Session B

Session Time: 10:30AM-12:30PM

Background/Purpose: The Pediatric Rheumatology Care and Outcomes Improvement Network (PR-COIN) has a mission to deliver exceptional and equitable health care to children with rheumatic diseases with a current focus on patients with juvenile idiopathic arthritis (JIA). PR-COIN’s registry tracks outcome, process, data quality, and balancing measures. PR-COIN assesses and addresses disparities across demographic variables by creating network SMARTIE (specific, measurable, actionable, realistic, time-bound, inclusive, equitable) aims. One aim is to increase the percent of patients with oligoarticular and polyarticular JIA who have inactive or low disease activity by the 10-joint clinical Juvenile Arthritis Disease Activity Score (cJADAS10) from 81.6% to 85% in addition to decreasing the gap between patients with commercial insurance and Medicaid from 8.8% to 5% by December 31, 2025. An additional aim is to increase the percent of patients with JIA in no pain or with mild pain intensity from 80.6% to 83% while decreasing the disparity gap between Black and White patients from 9% to 5% during this same timeframe.

Methods: A key driver diagram was created highlighting the SMARTIE aims and identifying key drivers and change ideas (Figure 1). Data from quality measures between January 2023-February 2025 were stratified by insurance type (comparing patients with commercial insurance and Medicaid) or race (comparing White and Black patients) for 2 outcome measures – inactive or low disease activity by cJADAS10 and no or mild pain – and 2 process measures – receipt of self-management support (SMS) and completion of setting a treatment target of disease activity. The differences in subgroup medians portrayed on run charts were translated to run charts of disparity gaps.

Results: Patients with JIA on commercial insurance consistently have a higher rate of inactive or low disease activity compared to patients on Medicaid (Figure 2A). The disparity gap between these populations decreased from 10% to 9% in November 2023 (Figure 2B). The percent of White and Black patients with no or mild pain have both increased slightly since January 2023 (currently 82.8% and 73.8%, respectively), although the disparity gap of 8.8% has been stable throughout this period (Figure 3). White patients are more likely to receive SMS compared to Black patients with a disparity gap of 7.7%. Patients on Medicaid were more likely to have a treatment target set than patients with commercial insurance (33.4% and 27.7%, respectively).

Conclusion: PR-COIN is striving to provide equitable health care to patients with JIA by making health equity a strategic priority, setting network aims with a health equity focus, and by assessing for differences in health outcomes related to social or demographic factors. We found a disparity by insurance type in our inactive or low disease activity measure. Disparities by race were present in pain intensity score and receipt of SMS. A focus on treatment target setting with patients on Medicaid may mitigate disparities in outcomes. PR-COIN will continue to monitor and address these disparity gaps over time to improve care for all patients with JIA. Further research into persistence of disparities is warranted.

Supporting image 1Figure 1. PR-COIN’s key driver diagram.

Supporting image 2Figure 2. Run charts demonstrating inactive or low disease activity by insurance status (A) and the gap in performance by insurance status (B).

Supporting image 3Figure 3. Run charts demonstrating no or mild pain by race (A) and the gap in performance by race (B).


Disclosures: J. Harris: None; C. Bingham: None; S. Vora: None; J. Burnham: Cabaletta Bio, 5; C. Yildirim-Toruner: None; T. Lee: None; K. Ferraro: Abby's Army, 3, 8, 12, President; E. Friedrichsen: None; K. Banschbach: None; M. Batthish: None; D. Fair: None; M. Gilbert: None; B. Gottlieb: None; M. Mannion: None; E. Oberle: Pfizer, 1; N. Pan: None; N. Rosenwasser: None; M. Toth: None; J. Weiss: None; E. Morgan: None.

To cite this abstract in AMA style:

Harris J, Bingham C, Vora S, Burnham J, Yildirim-Toruner C, Lee T, Ferraro K, Friedrichsen E, Banschbach K, Batthish M, Fair D, Gilbert M, Gottlieb B, Mannion M, Oberle E, Pan N, Rosenwasser N, Toth M, Weiss J, Morgan E. Assessing Disparities in Outcomes and Processes of Care for Patients with Juvenile Idiopathic Arthritis in the Pediatric Rheumatology Care and Outcomes Improvement Network [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/assessing-disparities-in-outcomes-and-processes-of-care-for-patients-with-juvenile-idiopathic-arthritis-in-the-pediatric-rheumatology-care-and-outcomes-improvement-network/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessing-disparities-in-outcomes-and-processes-of-care-for-patients-with-juvenile-idiopathic-arthritis-in-the-pediatric-rheumatology-care-and-outcomes-improvement-network/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology